CORAL LABORATORIES
|
CORAL LABORATORIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 45.85 | 67.61 | 44.19 | 18.04 | 25.32 |
| CEPS(Rs) | 51.83 | 73.24 | 49.72 | 24.14 | 30.89 |
| DPS(Rs) | 2.00 | 1.50 | 2.00 | - | - |
| Book NAV/Share(Rs) | 585.33 | 563.19 | 496.83 | 433.29 | 436.81 |
| Tax Rate(%) | 29.13 | 25.61 | 23.84 | 21.65 | 23.70 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 17.71 | 22.82 | 19.41 | 4.88 | 10.86 |
| EBIT Margin(%) | 27.11 | 28.32 | 24.78 | 10.96 | 15.87 |
| Pre Tax Margin(%) | 26.91 | 28.23 | 24.78 | 10.53 | 15.68 |
| PAT Margin (%) | 19.07 | 21.00 | 18.87 | 8.25 | 11.96 |
| Cash Profit Margin (%) | 21.56 | 22.75 | 21.23 | 11.04 | 14.60 |
| Performance Ratios | |||||
| ROA(%) | 6.97 | 11.10 | 8.31 | 3.54 | 5.06 |
| ROE(%) | 7.98 | 12.76 | 9.50 | 4.15 | 6.18 |
| ROCE(%) | 11.14 | 17.04 | 12.48 | 5.41 | 7.87 |
| Asset Turnover(x) | 0.37 | 0.53 | 0.44 | 0.43 | 0.42 |
| Sales/Fixed Asset(x) | 1.41 | 2.29 | 1.68 | 1.64 | 1.74 |
| Working Capital/Sales(x) | 0.57 | 0.76 | 0.65 | 0.70 | 0.72 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.71 | 0.44 | 0.59 | 0.61 | 0.58 |
| Receivable days | 134.00 | 98.13 | 112.59 | 143.76 | 186.51 |
| Inventory Days | 64.59 | 39.72 | 60.34 | 72.11 | 96.64 |
| Payable days | 146.86 | 102.34 | 146.79 | 75.80 | 167.30 |
| Valuation Parameters | |||||
| PER(x) | 8.08 | 10.37 | 8.40 | 12.69 | 10.08 |
| PCE(x) | 7.15 | 9.58 | 7.47 | 9.48 | 8.26 |
| Price/Book(x) | 0.63 | 1.25 | 0.75 | 0.53 | 0.58 |
| Yield(%) | 0.54 | 0.21 | 0.54 | - | - |
| EV/Net Sales(x) | 0.75 | 1.52 | 0.85 | 0.53 | 0.79 |
| EV/Core EBITDA(x) | 2.56 | 4.93 | 3.12 | 3.86 | 4.59 |
| EV/EBIT(x) | 2.76 | 5.35 | 3.44 | 4.83 | 4.98 |
| EV/CE(x) | 0.30 | 0.85 | 0.40 | 0.27 | 0.31 |
| M Cap / Sales | 1.54 | 2.18 | 1.59 | 1.05 | 1.21 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -25.31 | 37.47 | 7.09 | 3.32 | -21.70 |
| Core EBITDA Growth(%) | -28.96 | 54.55 | 113.62 | -17.82 | -33.60 |
| EBIT Growth(%) | -28.50 | 57.09 | 142.07 | -28.61 | -32.05 |
| PAT Growth(%) | -32.18 | 52.99 | 144.97 | -28.75 | -33.26 |
| EPS Growth(%) | -32.18 | 52.99 | 144.97 | -28.75 | -33.26 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.02 | - | - | 0.04 |
| Current Ratio(x) | 6.48 | 7.07 | 6.18 | 10.42 | 5.13 |
| Quick Ratio(x) | 5.73 | 6.68 | 5.57 | 9.36 | 4.41 |
| Interest Cover(x) | 135.86 | 333.69 | - | 25.30 | 85.02 |
| Total Debt/Mcap(x) | 0.03 | 0.01 | - | - | 0.07 |
Compare Financial Ratios of peers of CORAL LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORAL LABORATORIES | ₹178.1 Cr | 2.2% | -10.4% | -2.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
CORAL LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORAL LABORATORIES | 2.2% |
-10.4% |
-2.6% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses
